This novel anti-infective, invented by Orchid Pharma, aims to address the rising threat of antimicrobial resistance (AMR) and has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP)
Read More
The integration is expected to enhance efficiency, reduce errors, and streamline processes, ultimately doubling Urmedz's order processing capacity
Read More
Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by 2050
Read More
The facility has been granted a Voluntary Action Indicated (VAI) status following an inspection that took place from May 7 to May 17, 2024
Read More
A study by business consultancy firm Grand View Research has estimated that the global pharma robotics market will expand at a CAGR of 8.7 per cent from 2023 to 2030 to reach USD 357.9 million by the end of this decade
Read More
The theme for this year’s event is "Advances in Manufacturing and Quality – Patient Centricity."
Read More
The transaction has been executed through the Kotak Strategic Situations Fund II
Read More
The investment, in exchange for an undisclosed equity stake, is set to expedite Orbicular's product pipeline development
Read More
On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
In Q4 FY24, Mankind Pharma reported revenue from operations of Rs 2,441 Cr, marking a notable 19 per cent year-on-year (YoY) increase
Read More
